Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532-2561. doi:10.1016/S0140-6736(16)31357-5.
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. Diabetes Care. 2016;pii: dc152322. .
Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China. Circulation. 2016;133:2545-60..
The Effects of a Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized Trial. PLoS One. 2016;11:e0166620.
A user-centred home monitoring and self-management system for patients with heart failure: A multi-centre cohort study.; 2015.
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. 2015;8:87-95.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2015;387:435-443.
Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme. Lancet. 2015;385 Suppl 2:S23.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. Hypertension. 2015;65:115-21.
The epidemiology of blood pressure and its worldwide management. Circulation Research. 2015;116:925-36..
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591-8.
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial. Journal of Neurology, Neurosurgery, and Psychiatry. 2014;pii: jnnp-2014-307856.
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Medicine. 2014;11:e1001699.
Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health. 2014;14:345.
Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Failure. 2014;2:440-6.
SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India. JMIR Mhealth Uhealth. 2014;2:e54.
The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. International Journal of Cardiology. 2014;176(3):718-23.
A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science. 2013;8:137.
Baseline cognitive function, recurrent stroke, and risk of dementia in stroke patients. Stroke. 2013;44:1790-95.
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680. doi:10.1136/bmj.f5680.
Blood pressure-lowering and major cardiovascular events in people with and without chronic kidney disease: a meta-analysis of randomised controlled trials. British Medical Journal. 2013;347.
China Rural Health Initiative – Primary care provider study: A large cluster-randomized controlled trial of high cardiovascular risk management in rural China. In: American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Science: Special Reports. American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Science: Special Reports. Dallas, Texas, USA; 2013.
China Rural Health Initiative – Sodium Reduction Study: the effect of a community-based sodium reduction program on 24hr urinary sodium and blood pressure in rural China. In: American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Trials. American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Trials. Dallas, Texas, USA; 2013.